Literature DB >> 19109772

Cancer occurrence.

Ahmedin Jemal1, Melissa M Center, Elizabeth Ward, Michael J Thun.   

Abstract

In this chapter, we describe the variability of cancer occurrence by using measures of incidence, mortality, prevalence, and survival, according to demographic characteristics such as age, sex, socioeconomic status, and race/ethnicity, as well as geographic location and time period. We also discuss the variability of cancer occurrence in relation to changes in risk factors, screening rates, and improved treatments. The variation according to risk factors provides strong evidence that much of cancer is caused by environmental factors and is potentially avoidable.

Entities:  

Mesh:

Year:  2009        PMID: 19109772     DOI: 10.1007/978-1-59745-416-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  47 in total

1.  Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT.

Authors:  Cristina Zaccaro; Ilaria Maria Saracino; Giulia Fiorini; Natale Figura; John Holton; Valentina Castelli; Valeria Pesci; Luigi Gatta; Dino Vaira
Journal:  Intern Emerg Med       Date:  2017-02-02       Impact factor: 3.397

Review 2.  "Unresectable" vulval cancers: is neoadjuvant chemotherapy the way forward?

Authors:  Kathryn Graham; Kevin Burton
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 3.  Autophagy and endocrine resistance in breast cancer.

Authors:  Katherine L Cook; Ayesha N Shajahan; Robert Clarke
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

Review 4.  Colorectal carcinogenesis--update and perspectives.

Authors:  Hans Raskov; Hans-Christian Pommergaard; Jakob Burcharth; Jacob Rosenberg
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  4FISH-IF, a four-color dual-gene FISH combined with p63 immunofluorescence to evaluate NKX3.1 and MYC status in prostate cancer.

Authors:  Dominique Trudel; Gaetano Zafarana; Jenna Sykes; Cherry L Have; Robert G Bristow; Theo van der Kwast
Journal:  J Histochem Cytochem       Date:  2013-05-02       Impact factor: 2.479

6.  Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.

Authors:  Yong Gao; Zhiliang Jia; Xiangyu Kong; Qiang Li; David Z Chang; Daoyan Wei; Xiangdong Le; Huang Suyun; Shengdong Huang; Liwei Wang; Keping Xie
Journal:  Cancer Res       Date:  2011-06-14       Impact factor: 12.701

7.  Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse.

Authors:  Jamie L McClellan; J Mark Davis; Jennifer L Steiner; Stani D Day; Susan E Steck; Martin D Carmichael; E Angela Murphy
Journal:  Cytokine       Date:  2011-11-04       Impact factor: 3.861

8.  Unanticipated toxicities from anticancer therapies: survivors' perspectives.

Authors:  Mona Gandhi; Karen Oishi; Beth Zubal; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2009-12-03       Impact factor: 3.603

9.  Early detection of and screening for colorectal neoplasia.

Authors:  Robert S Bresalier
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

10.  N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.

Authors:  Kathy B Baumgartner; Thomas J Schlierf; Dongyan Yang; Mark A Doll; David W Hein
Journal:  Toxicol Sci       Date:  2009-08-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.